Statistics for Biotalys NV (id:393 BTLS)

Valuation metrics

Market cap

111.62M

Enterprise value

86.62M

Trailing P/E (ttm)

-4.51

Forward P/E

-7.45

PEG ratio

-7.45

Price/Sales (ttm)

Price/Book (mrq)

4.89

Enterprise Value/Revenue

Enterprise Value/EBITDA

-5.74

Overview

Shares outstanding

37.46M

Float

9.20M

Shares short

% Held by insiders

0.48%

% Held by institutions

0.23%

Average volume (10 days)

11.25K

Average volume (90 days)

Price summary

52-Week low

1.62

52-Week high

5.34

52-Week change

32.08%

Beta

0.93

50-Day moving average

3.14

200-Day moving average

3.10

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2021

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-27.07%

Return on equity

-59.66%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-15,094,000.00

Net income to common (ttm)

-16,335,000.00

Diluted EPS (ttm)

-0.51

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

14.68M

Total cash per share (mrq)

0.46

Total debt (mrq)

5.48M

Total Debt/Equity (mrq)

28.02

Current ratio (mrq)

388.20%

Book value per share (mrq)

0.61

Cash flow

Cash flow statement

-16,294,000.00

Levered free cash flow (LFCF)

-11,381,500.00